Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. Qian T, Fujiwara N, Koneru B, Ono A, et al. Gastroenterology 2022;162:1210-1225.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qian T, Fujiwara N, Koneru B, Ono A, et al. Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. Gastroenterology 2022;162:1210-1225.
PMID: 34951993